Pan B-Cell Markers Are Not Redundant in Analysis of Chronic Lymphocytic Leukemia (CLL)

Sara A. Monaghan, LoAnn C. Peterson, Cathy James, Laura Marszalek, Adela Khoong, Dina J. Bachta, William J. Karpus, Charles L. Goolsby

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: The classic immunophenotype for chronic lymphocytic leukemia (CLL) is CD19+, restricted dim surface expression of kappa or lambda light chain, CD5+, CD23+, dim CD20+, negative FMC7, and negative CD79b. However, the necessity of assaying for all 3 pan B-cell markers (CD20, FMC7, and CD79b) by flow cytometry has not been definitively documented for CLL. Methods: Qualitative patterns and semi-quantitative assessment of staining intensity for CD20, FMC7 and CD79b were performed in 70 cases with a current or prior diagnosis of CLL or CLL with increased prolymphocytes leukemia (CLL/PL). The concurrent morphology in 66 of 70 specimens was classified as typical CLL in 53 cases, CLL/PL in 10 cases, and large cell lymphoma in 3 cases. Results: Forty percent of the cases varied from the characteristic immunophenotype by having moderate or bright staining of CD20 (36%), FMC7 (7%), and/or CD79b (18%). Discrepant qualitative staining patterns were found between FMC7 and CD20 (21%), CD20 and CD79b (15%), and CD79b and FMC7 (10%). Semiquantitative measurement of staining intensity showed little correlation between CD79b and CD20 or FMC7. Moderate correlation was seen between CD20 and FMC7. No correlation was observed between morphology and intensity of marker expression. Conclusions: Variable patterns and intensity of staining were seen for FMC7, CD20, and CD79b in this cohort of CLL samples. Dim or negative staining was most consistently seen for FMC7 (93% of specimens). Although FMC7 staining intensity was moderately correlated with CD20, CD79b intensity was poorly correlated with either CD20 or FMC7, and thus, may provide some independent information.

Original languageEnglish (US)
Pages (from-to)30-42
Number of pages13
JournalCytometry Part B - Clinical Cytometry
Volume56
Issue number1
StatePublished - Nov 2003

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Staining and Labeling
Negative Staining
Lymphoma
Flow Cytometry
Leukemia
Light

Keywords

  • CD20
  • CD79b
  • Chronic lymphocytic leukemia
  • Flow cytometry
  • FMC7
  • Immunophenotype

ASJC Scopus subject areas

  • Hematology
  • Cell Biology
  • Pathology and Forensic Medicine
  • Biophysics
  • Endocrinology

Cite this

Monaghan, S. A., Peterson, L. C., James, C., Marszalek, L., Khoong, A., Bachta, D. J., ... Goolsby, C. L. (2003). Pan B-Cell Markers Are Not Redundant in Analysis of Chronic Lymphocytic Leukemia (CLL). Cytometry Part B - Clinical Cytometry, 56(1), 30-42.

Pan B-Cell Markers Are Not Redundant in Analysis of Chronic Lymphocytic Leukemia (CLL). / Monaghan, Sara A.; Peterson, LoAnn C.; James, Cathy; Marszalek, Laura; Khoong, Adela; Bachta, Dina J.; Karpus, William J.; Goolsby, Charles L.

In: Cytometry Part B - Clinical Cytometry, Vol. 56, No. 1, 11.2003, p. 30-42.

Research output: Contribution to journalArticle

Monaghan, SA, Peterson, LC, James, C, Marszalek, L, Khoong, A, Bachta, DJ, Karpus, WJ & Goolsby, CL 2003, 'Pan B-Cell Markers Are Not Redundant in Analysis of Chronic Lymphocytic Leukemia (CLL)', Cytometry Part B - Clinical Cytometry, vol. 56, no. 1, pp. 30-42.
Monaghan, Sara A. ; Peterson, LoAnn C. ; James, Cathy ; Marszalek, Laura ; Khoong, Adela ; Bachta, Dina J. ; Karpus, William J. ; Goolsby, Charles L. / Pan B-Cell Markers Are Not Redundant in Analysis of Chronic Lymphocytic Leukemia (CLL). In: Cytometry Part B - Clinical Cytometry. 2003 ; Vol. 56, No. 1. pp. 30-42.
@article{dca6b0227e744d31abc5e84b598980cb,
title = "Pan B-Cell Markers Are Not Redundant in Analysis of Chronic Lymphocytic Leukemia (CLL)",
abstract = "Background: The classic immunophenotype for chronic lymphocytic leukemia (CLL) is CD19+, restricted dim surface expression of kappa or lambda light chain, CD5+, CD23+, dim CD20+, negative FMC7, and negative CD79b. However, the necessity of assaying for all 3 pan B-cell markers (CD20, FMC7, and CD79b) by flow cytometry has not been definitively documented for CLL. Methods: Qualitative patterns and semi-quantitative assessment of staining intensity for CD20, FMC7 and CD79b were performed in 70 cases with a current or prior diagnosis of CLL or CLL with increased prolymphocytes leukemia (CLL/PL). The concurrent morphology in 66 of 70 specimens was classified as typical CLL in 53 cases, CLL/PL in 10 cases, and large cell lymphoma in 3 cases. Results: Forty percent of the cases varied from the characteristic immunophenotype by having moderate or bright staining of CD20 (36{\%}), FMC7 (7{\%}), and/or CD79b (18{\%}). Discrepant qualitative staining patterns were found between FMC7 and CD20 (21{\%}), CD20 and CD79b (15{\%}), and CD79b and FMC7 (10{\%}). Semiquantitative measurement of staining intensity showed little correlation between CD79b and CD20 or FMC7. Moderate correlation was seen between CD20 and FMC7. No correlation was observed between morphology and intensity of marker expression. Conclusions: Variable patterns and intensity of staining were seen for FMC7, CD20, and CD79b in this cohort of CLL samples. Dim or negative staining was most consistently seen for FMC7 (93{\%} of specimens). Although FMC7 staining intensity was moderately correlated with CD20, CD79b intensity was poorly correlated with either CD20 or FMC7, and thus, may provide some independent information.",
keywords = "CD20, CD79b, Chronic lymphocytic leukemia, Flow cytometry, FMC7, Immunophenotype",
author = "Monaghan, {Sara A.} and Peterson, {LoAnn C.} and Cathy James and Laura Marszalek and Adela Khoong and Bachta, {Dina J.} and Karpus, {William J.} and Goolsby, {Charles L.}",
year = "2003",
month = "11",
language = "English (US)",
volume = "56",
pages = "30--42",
journal = "Cytometry Part B - Clinical Cytometry",
issn = "1552-4949",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Pan B-Cell Markers Are Not Redundant in Analysis of Chronic Lymphocytic Leukemia (CLL)

AU - Monaghan, Sara A.

AU - Peterson, LoAnn C.

AU - James, Cathy

AU - Marszalek, Laura

AU - Khoong, Adela

AU - Bachta, Dina J.

AU - Karpus, William J.

AU - Goolsby, Charles L.

PY - 2003/11

Y1 - 2003/11

N2 - Background: The classic immunophenotype for chronic lymphocytic leukemia (CLL) is CD19+, restricted dim surface expression of kappa or lambda light chain, CD5+, CD23+, dim CD20+, negative FMC7, and negative CD79b. However, the necessity of assaying for all 3 pan B-cell markers (CD20, FMC7, and CD79b) by flow cytometry has not been definitively documented for CLL. Methods: Qualitative patterns and semi-quantitative assessment of staining intensity for CD20, FMC7 and CD79b were performed in 70 cases with a current or prior diagnosis of CLL or CLL with increased prolymphocytes leukemia (CLL/PL). The concurrent morphology in 66 of 70 specimens was classified as typical CLL in 53 cases, CLL/PL in 10 cases, and large cell lymphoma in 3 cases. Results: Forty percent of the cases varied from the characteristic immunophenotype by having moderate or bright staining of CD20 (36%), FMC7 (7%), and/or CD79b (18%). Discrepant qualitative staining patterns were found between FMC7 and CD20 (21%), CD20 and CD79b (15%), and CD79b and FMC7 (10%). Semiquantitative measurement of staining intensity showed little correlation between CD79b and CD20 or FMC7. Moderate correlation was seen between CD20 and FMC7. No correlation was observed between morphology and intensity of marker expression. Conclusions: Variable patterns and intensity of staining were seen for FMC7, CD20, and CD79b in this cohort of CLL samples. Dim or negative staining was most consistently seen for FMC7 (93% of specimens). Although FMC7 staining intensity was moderately correlated with CD20, CD79b intensity was poorly correlated with either CD20 or FMC7, and thus, may provide some independent information.

AB - Background: The classic immunophenotype for chronic lymphocytic leukemia (CLL) is CD19+, restricted dim surface expression of kappa or lambda light chain, CD5+, CD23+, dim CD20+, negative FMC7, and negative CD79b. However, the necessity of assaying for all 3 pan B-cell markers (CD20, FMC7, and CD79b) by flow cytometry has not been definitively documented for CLL. Methods: Qualitative patterns and semi-quantitative assessment of staining intensity for CD20, FMC7 and CD79b were performed in 70 cases with a current or prior diagnosis of CLL or CLL with increased prolymphocytes leukemia (CLL/PL). The concurrent morphology in 66 of 70 specimens was classified as typical CLL in 53 cases, CLL/PL in 10 cases, and large cell lymphoma in 3 cases. Results: Forty percent of the cases varied from the characteristic immunophenotype by having moderate or bright staining of CD20 (36%), FMC7 (7%), and/or CD79b (18%). Discrepant qualitative staining patterns were found between FMC7 and CD20 (21%), CD20 and CD79b (15%), and CD79b and FMC7 (10%). Semiquantitative measurement of staining intensity showed little correlation between CD79b and CD20 or FMC7. Moderate correlation was seen between CD20 and FMC7. No correlation was observed between morphology and intensity of marker expression. Conclusions: Variable patterns and intensity of staining were seen for FMC7, CD20, and CD79b in this cohort of CLL samples. Dim or negative staining was most consistently seen for FMC7 (93% of specimens). Although FMC7 staining intensity was moderately correlated with CD20, CD79b intensity was poorly correlated with either CD20 or FMC7, and thus, may provide some independent information.

KW - CD20

KW - CD79b

KW - Chronic lymphocytic leukemia

KW - Flow cytometry

KW - FMC7

KW - Immunophenotype

UR - http://www.scopus.com/inward/record.url?scp=1442276358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442276358&partnerID=8YFLogxK

M3 - Article

C2 - 14582135

AN - SCOPUS:1442276358

VL - 56

SP - 30

EP - 42

JO - Cytometry Part B - Clinical Cytometry

JF - Cytometry Part B - Clinical Cytometry

SN - 1552-4949

IS - 1

ER -